Results

Total Results: 1,544 records

Showing results for "drug".

21. Cancer-Drugs-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
    January 01, 2011 - Not all biologics are Food and Drug Administration-labeled (i.e., indicated) for the conditions in which … developed guide- lines for medically accepted off-label use of anticancer biologics, using published drug … integrate information from five various compendia providers (American Hospital Formulary Service Drug … Prescription Drug Event (PDE) data were used to identify Medicare Part D eligibility and biolog- ics … , Active Ingredient, Age, Gender, and Race, 2006-2009 Proportion of FFS Drug Users With a 200.x-208

22. White Paper: Enhancing Systematic Review Methods by Incorporating Unpublished Drug Trials (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
    December 01, 2024 - Food and Drug Administration (FDA) drug approval packages (i.e., FDA reviews) into three systematic … Food and Drug Administration (FDA). … Food and Drug Administration. 7 4. … Drug Class Reviews. … Food and Drug Administration; 2001.

23. Cancer-Drugs-Utilization-Cost Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
    January 01, 2011 - Medicare fee-for-service (FFS) payments (excluding Part C advantage plans and Part D prescription drug … costs to prescription drug plans. … Peginterferon alfa-2a ranked highest among anticancer biologics, at #9.7 Although the Food and Drug … Drug Event (PDE) file, a dataset containing summary records of drug dispensing from prescription drug … Biotech drug spending increases 21 percent even as growth in rx expenditure slows.

24. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient The DEcIDE ( … Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. … Clopidogrel after drug-eluting stent implantation: is current practice sufficient? … Of the 4666 patients remaining, 3165 received a bare metal and 1501 a drug-eluting stent. … : an observational study of drug-eluting versus bare-metal stents.

25. Chicago-Area DEcIDE Center (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - and drug interactions. … Food and Drug Administration, Center for Drug Evaluation and Review. … /Drug Safety Diane Kennedy, RPh, MPH Food and Drug Administration Regulator/Drug Analysis Laurie … has serious side effects.** 2) The drug has frequent side effects. 3) The drug has serious drug-drug … interactions.** 4) The drug has frequent drug-drug interactions.* 5) The drug is approved in other

26. App-F1-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Sleep outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Pain severity for fibroyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 … Anxiety outcomes for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Sleep outcomes for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug

27. Data-Points-9 Maps (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_maps.pdf
    May 29, 2025 - 2009 Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Insulin Among Diabetic Beneficiaries With At Least One Antidiabetic Drug

28. App-F1-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Sleep outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Pain severity for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 … Anxiety outcomes for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Sleep outcomes for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug

29. S96 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - Key Words: adverse drug reaction reporting systems, surveillance, drug safety (Med Care 2007;45: S96 … –S102) An adverse drug event (ADE) occurs when a drug intended for therapeutic use has an unintended … or a drug-specific effect. … How the US Food and Drug Administration defines and detects adverse drug events. … Incidence of adverse drug events and potential adverse drug events. Implications for prevention.

30. Improving Medication Safety in High Risk Medicare Beneficiaries Toolkit (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
    July 01, 2012 - events) and real (adverse drug events being a subset of the drug related problems) drug related problems … events, and assess medication appropriateness, potential drug-drug and drug-food interactions, dose … drug related problems. … The patient is having an adverse drug event (ADE) as a result of the drug. a. … Does the patient have an allergy to the drug or similar drug? (7.1) b.

31. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Sleep outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Pain severity for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 … Anxiety outcomes for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Sleep outcomes for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug

32. Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018

33. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time

34. Management of Acute Diverticulitis Additional Information for Topic Nomination (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-nomination-extra.pdf
    May 29, 2025 - interventional radiology) • Surgical resection with primary anastomosis • Hartmann’s procedure Drug … (ex. 5-amino salicylates, etc.) and non- drug (ex. dietary) interventions KQ1: Antibiotics KQ1 … Hartmann's procedure No intervention, other drug, other non-drug, drug vs. non-drug, combinations

35. App-F2-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of naproxen versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time

36. Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/high-risk-drugs/protocol

37. S9 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
    October 01, 2007 - drug subsidy. … Coverage for the prescription drug benefit is provided under various types of prescription drug plans … ) prescription drug plans (MA-PDPs), which offer prescription drug coverage that is integrated with the … Medicare Part D Prescription Drug Event (PDE) Data. … Total Medicare Beneficiaries With Drug Coverage as of June 11, 2006 Description June (Millions) Drug

38. S13 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - , or the drug indication itself. … to prove drug efficacy (ie, the possibility of a beneficial effect in an ideal setting), but not drug … effec- tiveness (ie, whether the drug works in reality).3 Further, information on comparative drug effectiveness … type, how long the drug has been taken, how recently the drug was taken, and demographics of the patient … US Food and Drug Administration.

39. Cover Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
    September 01, 2007 - for monitoring and detecting adverse drug events. … Detecting adverse drug events is a difficult problem. … interactions and monitoring drug safety. … (Center for Drug Evaluation and Research [CDER], 2005). … Reporting mechanisms need to be customized for each drug and drug combinations to collect relevant

40. Cover Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
    September 01, 2007 - for monitoring and detecting adverse drug events. … Detecting adverse drug events is a difficult problem. … interactions and monitoring drug safety. … (Center for Drug Evaluation and Research [CDER], 2005). … Reporting mechanisms need to be customized for each drug and drug combinations to collect relevant